Financial statements are reported in CHF and shown here converted to USD at today's exchange rate.
RHHBY — Roche Holding AG
$60.30
$-0.20 (-0.33%)
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.
Market Cap
$384.36B
Forward P/E
18.1x
52-Week Range
N/A
RHHBY Price History
Revenue vs. Net Income
$73.4B
Revenue · FY2025
Annual. Net margin is shown under each year.
Free Cash Flow
$15.6B
FCF · FY2025
Annual. FCF margin is shown under each year.
Return on Capital Employed (ROCE)
25.2%
ROCE · FY2025
Annual. Green above 0%, red below. Dashed line marks the 15% compounder threshold.
Total Assets vs. Total Liabilities
1.5x
Assets ÷ liabilities · FY2025
Annual. What the company owns against what it owes. Assets ÷ liabilities is shown under each year.
CapEx as % of Revenue
9.4%
CapEx · FY2025
Annual. Green at or under the 5% maximum target, red above it.
Shares Outstanding
+0.1%
Dilution · FY2025
Annual diluted shares. Under each year: the change on the previous year (green = buyback, amber = dilution).
